Cawachi Limited operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cawachi Limited with three other
companies in this sector in Japan:
Qol Co Ltd
sales of 145.52 billion Japanese Yen [US$1.32 billion]
AIN Pharmaciez Incorporation
(268.39 billion Japanese Yen [US$2.44 billion]
Nihon Chouzai, Co.,Ltd
(241.27 billion Japanese Yen [US$2.19 billion]
Cawachi Limited reported sales of ¥268.21 billion (US$2.44 billion)
March of 2018.
a very small
increase of 0.7%
versus 2017, when the company's sales were ¥266.42 billion.
Sales at Cawachi Limited have increased during each of the previous five years
(and since 2013, sales have increased a total of 16%).
Sales of Cosmetics saw an increase
that was more than double the company's growth rate: sales were up
3.5% in 2018, from
¥21.94 billion to ¥22.71 billion.
Cawachi Limited also saw significant increases in sales in
Pharmaceuticals (up 1.6% to ¥45.43 billion)
Not all segments of Cawachi Limited experienced an increase in sales in 2018:
sales of Miscellaneous Goods fell 0.5% to ¥76.00 billion.